Pettinga Financial Advisors, LLC Johnson & Johnson Transaction History

Pettinga Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	SELL	$111.14 - $153.99 $158,263 - $219,281	-1,424 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$127.5 - $146.44 $63,750 - $73,220	-500 Reduced 25.99%	1,424 $208,000
Q3 2019 Oct 17, 2019	BUY	$126.95 - $142.14 $12,695 - $14,213	100 Added 5.48%	1,924 $249,000
Q2 2019 Jul 31, 2019	SELL	$131.15 - $144.24 $51,279 - $56,397	-391 Reduced 17.65%	1,824 $254,000
Q1 2019 May 13, 2019	BUY	$125.72 - $139.79 $377 - $419	3 Added 0.14%	2,215 $310,000
Q4 2018 Feb 01, 2019	BUY	$122.84 - $147.84 $271,722 - $327,022	2,212 New	2,212 $286,000

4,258

1.68B

16.1M

13.8M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $397B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Pettinga Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Pettinga Financial Advisors, LLC with notifications on news.